---
title: "GSK boss says the US is the top spot for drug‑company investment"
summary: "GSK’s CEO, Emma Walmsley, says the United States is the best place for pharmaceutical companies to invest, citing the country’s leadership in drug launches and big markets like China. While the UK government is cutting the amount drug makers must pay back to the NHS, negotiations stalled and many big firms, including GSK, have paused or cancelled UK projects. GSK plans a £23 bn ($30 bn) investment in the US by 2030."
category: "NHS Healthcare Crisis"
section: "Business"
imageUrl: "https://media.guim.co.uk/b81bb2ffa5ffdad81780fd2bf8779dd392c9d127/152_0_1208_966/500.jpg"
publishedAt: "2025-12-11T16:20:45Z"
guardianId: "business/2025/dec/11/us-best-place-for-drugs-companies-invest-boss-gsk"
---

GSK’s CEO, Emma Walmsley, says the United States is the best place for pharmaceutical companies to invest, citing the country’s leadership in drug launches and big markets like China. While the UK government is cutting the amount drug makers must pay back to the NHS, negotiations stalled and many big firms, including GSK, have paused or cancelled UK projects. GSK plans a £23 bn ($30 bn) investment in the US by 2030.
